Browse studies

Find your next paid study

27,370 recruiting studies available now

Total RadIoTherapy of Oligometastatic caNcerS (TRITONS)

This is a Phase III non-blinded randomized study evaluating patients with oligometastatic cancers (up to 10 metastases). Subjects are randomized 1:1 to stereot…

Oligometastatic Malignant Solid Neoplasm

Estimated

~$50 – $1,500

Actual pay is set by the research site.

University of California, San DiegoNCT06587490

Serial Advanced Magnetic Resonance Imaging (MRI) for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

This study examines whether repeated magnetic resonance imaging (MRI)s scan helps identify changes in the tumor during radiation and chemotherapy treatment in …

Malignant Glioma

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT04771806

Phase 1

A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants With Advanced or Metastatic Solid Tumors

This Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), phar…

Advanced Solid TumorMetastatic Solid TumorEndometrial Cancer+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

MOMA TherapeuticsNCT06974110

Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test res…

Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Abramson Cancer Center at Penn MedicineNCT07471958

Observational

Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation

The research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and …

Post-COVID ConditionsObesity

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT05880108

Phase 2

Phase II Trial of Targeted Radiation With no Castration for Mcrpc

This trial tests if the combination of comprehensive metastasis directed therapy delivered by a precision form of external beam radiotherapy (stereotactic abla…

Prostate Cancer

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06084338

Observational

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Impact of IDP® Supplement on Respiratory Immune Health Outcomes During Cold and Flu Season in Older Individuals

The primary goal of this study is to observe the impact of the IDP® Supplement on the duration and severity of upper respiratory symptoms in older individuals …

Upper Respiratory DiseaseInfluenzaViral Upper Respiratory Infection

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Quantec LtdNCT07431840

Phase 4

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsy…

Alzheimer Disease

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Texas at AustinNCT03082755

Phase 1

A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors

The phase 1 primary objective is to determine the pediatric recommended phase 2 dose (RP2D) of PEEL-224 as a single agent (phase 1A) and in combination with vi…

Refractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Theodore LaetschNCT06721689

Phase 1

Phase 1 Dose-escalation Trial of OMTX705, an Anti-fibroblast Activation Protein Antibody-drug Conjugate, as Single Agent and in Combination With Anti-PD-1 in Patients With Advanced Solid Tumors

Open-label, two parallel arm, multicenter, Phase 1 dose-escalation study to evaluate the safety and tolerability of OMTX705, both as monotherapy or in combinat…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Oncomatryx Biopharma S.L.NCT05547321

Phase 2

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Low-dose MTX is a widely used, inexpensive, and safe therapy used for decades and is well tolerated by patients with rheumatologic diseases. Recently, it was i…

Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT06541249

Observational

Using Shared Decision Making to Improve Family Media Use Planning

Investigators will conduct a pilot randomized controlled trial assessing the efficacy and feasibility of the newly developed Family Media Check-In (FMC).

Adolescent Behavior

Estimated

~$10 – $750

Actual pay is set by the research site.

Seattle Children's HospitalNCT05722535